Credit Suisse Ag Compugen LTD Transaction History

Credit Suisse Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.57 - $3.33 $107,709 - $228,454	-68,605 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.76 - $4.64 $386 - $649	140 Added 0.2%	68,605 $221,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $14,875 - $26,040	3,637 Added 5.61%	68,465 $295,000
Q3 2021 Nov 12, 2021	SELL	$5.8 - $8.02 $25,763 - $35,624	-4,442 Reduced 6.41%	64,828 $387,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $457,383 - $609,845	-66,577 Reduced 49.01%	69,270 $574,000
Q1 2021 May 14, 2021	BUY	$7.67 - $13.77 $498,434 - $894,843	64,985 Added 91.71%	135,847 $1.17 Million
Q4 2020 Feb 12, 2021	BUY	$12.07 - $17.95 $182,039 - $270,721	15,082 Added 27.04%	70,862 $858,000
Q3 2020 Nov 13, 2020	BUY	$14.16 - $19.45 $86,899 - $119,364	6,137 Added 12.36%	55,780 $906,000
Q2 2020 Aug 12, 2020	BUY	$6.97 - $17.12 $346,011 - $849,888	49,643 New	49,643 $746,000

13.4M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $157M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.